- Home
- CLRO vs BFRI Comparison
CLRO vs BFRI Comparison
Compare CLRO & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLRO | BFRI |
|---|---|---|
| Founded | 1983 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3M | 16.3M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CLRO | BFRI |
|---|---|---|
| Price | $5.03 | $1.55 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | ★ 1.6M | 553.6K |
| Earning Date | 05-18-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 67.70 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $46,067,000.00 | $41,705,000.00 |
| Revenue This Year | N/A | $14.36 |
| Revenue Next Year | N/A | $16.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 11.59 | ★ 11.75 |
| 52 Week Low | $2.71 | $0.57 |
| 52 Week High | $16.50 | $1.61 |
Technical Indicators
Market Signals| Indicator | CLRO | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 44.97 | 62.73 |
| Support Level | $4.44 | $0.78 |
| Resistance Level | $5.40 | N/A |
| Average True Range (ATR) | 0.42 | 0.09 |
| MACD | -0.08 | -0.00 |
| Stochastic Oscillator | 17.40 | 63.37 |
Price Performance
Historical ComparisonAbout CLRO ClearOne Inc. (DE)
ClearOne Inc is currently engaged in activities that consist solely of fulfilling warranty and technical support obligations on legacy products, evaluating potential Strategic Transactions, managing and liquidating remaining assets of the company's legacy operating business, collecting accounts receivable and recovering prepaid assets, satisfying outstanding liabilities, and maintaining public-company compliance.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.